The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
Open accessAbstract
Atherosclerotic cardiovascular diseases (CVDs) are the biggest causes of death worldwide. In most people, CVD is the product of a number of causal risk factors. Several seemingly modest risk factors may, in combination, result in a much higher risk than an impressively raised single factor. For this reason, risk estimation systems have been developed to assist clinicians to assess the effects of risk factor combinations in planning management strategies. In this article, the performances of the major risk estimation systems are reviewed. Most perform usably well in populations that are similar to the one used to derive the system, and in other populations if calibrated to allow for different CVD mortality rates and different risk factor distributions. The effect of adding "new" risk factors to age, sex, smoking, lipid status, and blood pressure is usually small, but may help to appropriately reclassify some of those patients who are close to a treatment threshold to a more correct "treat/do not treat" category. Risk estimation in the young and old needs more research. Quantification of the hoped-for benefits of the multiple risk estimation approach in terms of improved outcomes is still needed. But, it is likely that the widespread use of such an approach will help to address the issues of both undertreatment and overtreatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most guidelines use one of these risk assessment systems [6-8].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [6]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used [6,8], can be used in any population regardless of baseline risk or secular changes in mortality, and therefore avoids the need for recalibration.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [6]
In the citing paper
“In practice, most risk estimation systems perform rather similarly when applied to populations recognizably similar to that from which the risk estimation system was derived, 6,7 and can be re-calibrated for use in different populations.6”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [6]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used, 51,52 which bypasses the dilemma of whether to use a risk estimation system based on CVD mortality or on the more attractive but less reliable endpoint of total CVD events.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
In the citing paper
“Most guidelines use one of these risk estimation systems. 50-52”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
In the citing paper
“Risk age has been shown to be independent of the CV endpoint used, 51,52”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Research works printed but not linked: 2
- De Backer, 2003, Eur J Cardiovasc Prev Rehabil, 10, 1
- 1996, Matching the intensity of risk factor management with the hazard for coronary disease events, J Am Coll Cardiol, 27, 957
Cited by
Sorted by citations
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citation2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Self-citationMancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Self-citationESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Self-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Self-citationWilliams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Self-citation2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,435
Self-citationThe Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216
Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
Kaptoge, S. K., Pennells, L. A. M., Bacquer, D. D., Cooney, M. T., Kavousi, M., Stevens, G. A., Riley, L. M., Savin, S., Khan, T., Altay, S., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30318-3 · Cited by 1,245
Self-citationCoronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction
Polonsky, T. S. (2010) · JAMA · doi:10.1001/jama.2010.461 · Cited by 1,123
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,389
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Braun, J. M., van den Berg, R., Baraliakos, X., Boehm, H., Burgos‐Vargas, R., Collantes‐Estévez, E., Dagfinrud, H. S., Dijkmans, B. A. C., Dougados, M., Emery, P., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151027 · Cited by 987
Erbel, R. M., Möhlenkamp, S., Moebus, S., Schmermund, A., Lehmann, N., Stang, A., Dragano, N., Grönemeyer, D. H. W., Seibel, R. M. M., Kälsch, H., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.030 · Cited by 783
Anderson, T. J., Grégoire, J. C., Hegele, R. A., Couture, P., Mancini, G. B. J., McPherson, R., Francis, G. A., Poirier, P., Lau, D. C. W., Grover, S. A., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.032 · Cited by 780
Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., De Carlo, M., Gallino, A., Landmesser, U., Laurent, S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.007 · Cited by 716
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Self-citationHypertension and cardiovascular risk: General aspects
Kjeldsen, S. E. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.003 · Cited by 694
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K. A., Cloutier, L., Gelfer, M., Lamarre-Cliché, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 690
Vlachopoulos, C. V., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., Carlo, M. D., Gallino, A., Landmesser, U., Laurent, S., et al. (2015) · HAL · Cited by 590
Fazel, S., Singh, J. P., Doll, H., & Grann, M. (2012) · BMJ · doi:10.1136/bmj.e4692 · Cited by 535
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 502
Self-citation2013 ESH/ESC Guidelines for the management of arterial hypertension
Mancia, G., Fagard, R. H., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T. C., Cífková, R., Backer, G. D., Dominiczak, A. F., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 430
Management of Measurable Variable Cardiovascular Disease' Risk Factors
Frančula-Zaninović, S., & Nola, I. A. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180222102312 · Cited by 409
Banegas, J. R., Lopez-Garcia, E., Dallongeville, J., Guallar, E., Halcox, J. P., Borghi, C., Masso-Gonzalez, E. L., Jimenez, F. J., Perk, J., Steg, P. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr080 · Cited by 354
Yano, Y., Reis, J. P., Colangelo, L. A., Shimbo, D., Viera, A. J., Allen, N. B., Gidding, S. S., Bress, A. P., Greenland, P., Muntner, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.13551 · Cited by 365
Quinn, R. R., Hemmelgarn, B. R., Padwal, R. S., Myers, M. G., Cloutier, L., Bolli, P., McKay, D. W., Khan, N. A., Hill, M. D., Mahon, J. L., et al. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70378-0 · Cited by 335
Maas, A. H. E. M., van der Schouw, Y. T., Regitz‐Zagrosek, V., Swahn, E., Appelman, Y., Pasterkamp, G., Cate, H. T., Nilsson, P. M., Huisman, M. V., Stam, H. C. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr048 · Cited by 299
McGorrian, C., Yusuf, S., Islam, S., Jung, H., Rangarajan, S., Avezum, Á., Prabhakaran, D., Almahmeed, W. A., Rumboldt, Z., Budaj, A., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq448 · Cited by 279
Caloric Sweetener Consumption and Dyslipidemia Among US Adults
Welsh, J. A. (2010) · JAMA · doi:10.1001/jama.2010.449 · Cited by 277
Consumption of Added Sugars and Indicators of Cardiovascular Disease Risk Among US Adolescents
Welsh, J. A., Sharma, A. J., Cunningham, S. A., & Vos, M. B. (2011) · Circulation · doi:10.1161/circulationaha.110.972166 · Cited by 269
KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 265
Collins, P. G. S., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c2442 · Cited by 250
Warner, T. D., Nylander, S., & Whatling, C. A. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03943.x · Cited by 249
A scalable discrete-time survival model for neural networks
Gensheimer, M. F., & Narasimhan, B. (2019) · PeerJ · doi:10.7717/peerj.6257 · Cited by 259
Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222
Self-citationGrover, S. A., Kaouache, M., Rempel, P., Joseph, L., Dawes, M. G., Lau, D. C. W., & Lowensteyn, I. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70229-3 · Cited by 233
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
Self-citationLachman, M. E., & Agrigoroaei, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013297 · Cited by 173
Pennells, L. A. M., Kaptoge, S. K., Wood, A., Sweeting, M., Zhao, X., White, I. R., Burgess, S., Willeit, P., Bolton, T. R., Moons, K. G. M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy653 · Cited by 164
Self-citationF. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
The Framingham Heart Study's Impact on Global Risk Assessment
Bitton, A., & Gaziano, T. A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.04.001 · Cited by 164
Perrone-Filardi, P., Achenbach, S., Möhlenkamp, S., Reiner, Z., Sambuceti, G., Schuijf, J. D., Van der Wall, E., Kaufmann, P. A., Knuuti, J., Schroeder, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq235 · Cited by 149
Cardiovascular risk assessment: a global perspective
Zhao, D. H., Liu, J., Xie, W., & Qi, Y. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.28 · Cited by 143
Intervention Thresholds and the Diagnosis of Osteoporosis
Kanis, J. А., McCloskey, E. V., Harvey, N. C., Johansson, H., & Leslie, W. D. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2531 · Cited by 131
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationCapodanno, D., Miano, M., Cincotta, G., Caggegi, A. M., Ruperto, C., Bucalo, R., Sanfilippo, A., Capranzano, P., & Tamburino, C. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.10.021 · Cited by 121
Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease
Tushuizen, M. E., Diamant, M., Sturk, A., & Nieuwland, R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200998 · Cited by 123
Vock, D. M., Wolfson, J. A., Bandyopadhyay, S., Adomavičius, G., Johnson, P. E., Vazquez‐Benitez, G., & O’Connor, P. J. (2016) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2016.03.009 · Cited by 126
Machine learning methodologies versus cardiovascular risk scores, in predicting disease risk
Dimopoulos, A. C., Νικολαϊδου, Μ., Caballero, F. F., Engchuan, W., Niubo, A. S., Arndt, H., Ayuso‐Mateos, J. L., Haro, J. M., Chatterji, S., Georgousopoulou, E. N., et al. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0644-1 · Cited by 118
Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study
Dallongeville, J., Banegas, J. R., Tubach, F., Güallar, E., Borghi, C., Backer, G. D., Halcox, J., Massó-González, E. L., Perk, J., Sazova, O., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711407705 · Cited by 108
Merlo, J., Mulinari, S., Wemrell, M., Subramanian, S. V., & Hedblad, B. (2017) · SSM - Population Health · doi:10.1016/j.ssmph.2017.08.005 · Cited by 102
DNA Damage: A Main Determinant of Vascular Aging
Bautista‐Niño, P. K., Portilla-Fernández, E., Vaughan, D. E., Danser, A. H. J., & Roks, A. J. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050748 · Cited by 95
Huang, Z., Dong, W., Duan, H., & Liu, J. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2731158 · Cited by 94
Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
Krähenbühl, S., Pavik-Mezzour, I., & von Eckardstein, A. (2016) · Drugs · doi:10.1007/s40265-016-0613-0 · Cited by 89
Bandyopadhyay, S., Wolfson, J. A., Vock, D. M., Vazquez‐Benitez, G., Adomavičius, G., Elidrisi, M., Johnson, P. E., & O’Connor, P. J. (2014) · Data Mining and Knowledge Discovery · doi:10.1007/s10618-014-0386-6 · Cited by 89
Liu, W., Laranjo, L., Klimis, H., Chiang, J., Yue, J., Marschner, S. L., Quiroz, J. C., Jorm, L. R., & Chow, C. K. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad017 · Cited by 91
Ghorpade, A. G., Shrivastava, S. R., Kar, S. S., Sarkar, S., Majgi, S. M., & Roy, G. (2015) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2015.88 · Cited by 79
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease
deGoma, E. M., Knowles, J. W., Angeli, F., Budoff, M. J., & Rader, D. J. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318239b924 · Cited by 81
Rinehart, S. J., Vazquez, G., Qian, Z., Murrieta, L., Christian, K., & Vörös, S. (2010) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2010.09.006 · Cited by 77
Abu-Assi, E., Gracía-Acuña, J. M., González, I. F., Peña, C., Díz, P., & González‐Juanatey, J. R. (2010) · Circulation · doi:10.1161/circulationaha.109.925594 · Cited by 71
Yannas, D., Frizza, F., Vignozzi, L., Corona, G., Maggi, M., & Rastrelli, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102221 · Cited by 68
Farrokhi, F. R., Buchlak, Q. D., Sikora, M., Esmaili, N., Marsans, M., McLeod, P. S., Mark, J., Cox, E. J., Bennett, C. C., & Carlson, J. D. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.10.063 · Cited by 73
Fazel, S., Wolf, A., Larsson, H., Lichtenstein, P., Mallett, S., & Fanshawe, T. R. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30109-8 · Cited by 67
Guía de la ESC/EAS sobre el manejo de las dislipemias
Reiner, Ž., Catapano, A. L., Backer, G. D., Graham, I. M., Taskinen, M., Wiklund, O., Agewall, S., Alegría, E., Chapman, M. J., Durrington, P. N., et al. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.09.014 · Cited by 64
Self-citationPrimary Prevention With Statins
Mortensen, M. B., Afzal, S., Nordestgaard, B. G., & Falk, E. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.089 · Cited by 65
van Daalen, K. R., Zhang, D., Kaptoge, S. K., Paige, E., Angelantonio, E. D., & Pennells, L. A. M. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00210-9 · Cited by 76
Kennedy, E. H., Wiitala, W. L., Hayward, R. A., & Sussman, J. B. (2012) · Medical Care · doi:10.1097/mlr.0b013e31827da594 · Cited by 67
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
Crowson, C. S., Rollefstad, S., Kitas, G. D., van Riel, P. L. C. M., Gabriel, S. E., & Semb, A. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174656 · Cited by 65
Mortensen, M. B., Nordestgaard, B. G., Afzal, S., & Falk, E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw426 · Cited by 61
Systematic Coronary Risk Evaluation (SCORE)
Graham, I. M., Angelantonio, E. D., Visseren, F. L. J., Bacquer, D. D., Ference, B. A., Timmis, A., Halle, M., Vardas, P. E., Huculeci, R., & Cooney, M. T. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.052 · Cited by 60
Self-citationHuang, W., Ying, T. W., Chin, W. L. C., Baskaran, L., Marcus, O. E. H., Yeo, K. K., & Kiong, N. S. (2022) · Scientific Reports · doi:10.1038/s41598-021-04649-y · Cited by 63
Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection
Hirasawa, K., Kokawa, A., Oka, H., Yahara, S., Sasaki, T., Nozawa, A., Morimoto, M., Numata, K., Taguri, M., Morita, S., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2011.07.067 · Cited by 60
Kanis, J. А., McCloskey, E. V., Harvey, N. C., Cooper, C. C., Rizzoli, R., Dawson-Hughes, B. F., Maggi, S., & Reginster, J. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06567-9 · Cited by 59
KONES, R. J. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710391350 · Cited by 58
Wu, S., Song, Y., Chen, S., Zheng, M., Ma, Y., Cui, L., & Jonas, J. B. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14239 · Cited by 55
External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations
Scheuermann, B., Brown, A. R., Colburn, T. D., Hakeem, H., Chow, C. H., & Ade, C. J. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.38311 · Cited by 58
Integrating Health into Cognitive Aging: Toward a Preventive Cognitive Neuroscience of Aging
Spiro, A., & Brady, C. B. (2011) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr018 · Cited by 53
A probabilistic topic model for clinical risk stratification from electronic health records
Huang, Z., Dong, W., & Duan, H. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.09.005 · Cited by 52
Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention
Mortensen, M. B., & Falk, E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw568 · Cited by 52
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
Zeitouni, M., Sabouret, P. F., Kernéis, M., Silvain, J., Collet, J., Bruckert, É., & Montalescot, G. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa077 · Cited by 55
CVD screening in low-risk, asymptomatic adults: clinical trials needed
Polonsky, T. S., & Greenland, P. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.114 · Cited by 50
Bozorgmanesh, M., Hadaegh, F., & Azizi, F. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02529.x · Cited by 48
Risk assessment in the prevention of cardiovascular disease in low-resource settings
Ofori, S., & Odia, O. J. (2015) · Indian Heart Journal · doi:10.1016/j.ihj.2015.07.004 · Cited by 48
Horne, B. D., Anderson, J. L., Muhlestein, J. B., Ridker, P. M., & Paynter, N. P. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487313519347 · Cited by 49
The Seattle spine score: Predicting 30-day complication risk in adult spinal deformity surgery
Buchlak, Q. D., Yanamadala, V., Leveque, J., Edwards, A. M., Nold, K., & Sethi, R. K. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.06.012 · Cited by 49
Abu‐Assi, E., García‐Acuña, J. M., Peña, C., & González‐Juanatey, J. R. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70156-1 · Cited by 47
Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score
Schuler, A., Walsh, D. M. A., Hall, D., Walsh, J., & Fisher, C. K. (2021) · The International Journal of Biostatistics · doi:10.1515/ijb-2021-0072 · Cited by 60
Schulberg, S. D., Ferry, A. V., Jin, K., Marshall, L., Neubeck, L., Strachan, F. E., & Mills, N. L. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15327 · Cited by 46
Risk and the Physics of Clinical Prediction
McEvoy, J. W., Diamond, G. A., Detrano, R., Kaul, S., Blaha, M. J., Blumenthal, R. S., & Jones, S. R. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.418 · Cited by 46
Zannad, F. M., Backer, G. D., Graham, I. M., Lorenz, M., Mancia, G., Morrow, D. A., Reiner, Ž., Köenig, W., Dallongeville, J., MacFadyen, R. J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01023.x · Cited by 47
Self-citationYano, Y., Kim, H. C., Lee, H., Azahar, N., Ahmed, S., Kitaoka, K., Kaneko, H., Kawai, F., Mizuno, A., & Viera, A. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18459 · Cited by 52
Reliability of a 3D Body Scanner for Anthropometric Measurements of Central Obesity
Medina‐Inojosa, J. R. (2016) · Obesity Open Access · doi:10.16966/2380-5528.122 · Cited by 44
Kasartzian, D.-I., & Tsiampalis, T. (2025) · Life · doi:10.3390/life15010094 · Cited by 52
Aspirin for Primary Prevention of Cardiovascular Disease Events
Nemerovski, C. W., Salinitri, F. D., Morbitzer, K. A., & Moser, L. R. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1127 · Cited by 43
Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review
Phulka, J., Ashraf, M., Bajwa, B. K., Paré, G., & Laksman, Z. (2023) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.122.003834 · Cited by 41
Metadata
- Authors
- Cooney, M. T., Dudina, A. L., & Graham, I. M.
- Affiliations
- Tallaght University Hospital (IE)
- Corresponding author
- Graham, Ian M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 54
- Issue
- 14
- Pages
- 1209-1227
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W197402492
- Cited by
- 436
- References
- 90
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 28 · 2021: 28 · 2020: 28 · 2019: 27 · 2018: 28 · 2017: 20 · 2016: 38 · 2015: 34 · 2014: 28 · 2013: 24 · 2012: 26
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- cardiovascular risk assessment, atherosclerotic cardiovascular disease, risk factor combinations, calibration, undertreatment, overtreatment, young and elderly patients, cardiovascular mortality
- MeSH terms
- Age Factors, Cardiovascular Diseases, Humans, Models, Cardiovascular, Risk Factors, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
